Literature DB >> 6987180

Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.

F A Klipstein, R F Engert.   

Abstract

The effect of route of administration, dosage, and number of boosts employed during immunization with the polymyxin-release form of Escherichia coli heat-labile (LT) enterotoxin on the degree and duration of protection afforded was evaluated in rats which were challenged by the ligated loop technique. Increasing the boosting dosage by fivefold from 50 to 250 mug resulted in a marked increase in protection against challenge with toxin in rats immunized either just by the parenteral route (i.p./i.p.) or by a parenteral prime, followed by peroral boosts (i.p./p.o.) in rats pretreated with cimetidine to ablate gastric secretions; such was not the case, however, even with a 50-fold increase in dosage in rats immunized just by the peroral route (p.o./p.o.). Four weekly peroral boosts were required to achieve the strongest degree of protection. Increasing the boosting dosage also increased the degree of protection against challenge with viable LT(+)/ST(-) and LT(+)/ST(+) strains (ST indicates heat-stable enterotoxin) in rats immunized by the i.p./p.o., but not by the i.p./i.p., route; no protection was evident against an LT(-)/ST(+) strain. Protection was lost within 3 weeks after immunization in rats immunized by the i.p./i.p. route. In contrast, protection was extended over the 3-month observation period in those immunized by the i.p./p.o. route; the degree of protection was enhanced in rats which received an additional boost at 2 months. These observations establish the fact that immunization with LT is similar to that with cholera toxin in that arousal of the local immune intestinal response by means of peroral immunization provides maximal extended protection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987180      PMCID: PMC550725          DOI: 10.1128/iai.27.1.81-86.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  In vitro production and inactivation of Escherichia coli enterotoxin.

Authors:  S T Donta; H W Moon; S C Whipp; S M Skartvedt
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

2.  The molecular nature of heat-labile enterotoxin (LT) of escherichia coli.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

3.  The relationship between two apparently different enterotoxins produced by enteropathogenic strains of Escherichia coli of porcine origin.

Authors:  H W Smith; C L Gyles
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

4.  Effect of purified Escherichia coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion.

Authors:  R A Giannella; K W Drake
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops.

Authors:  R B Sack; J Johnson; N F Pierce; D F Keren; J H Yardley
Journal:  J Infect Dis       Date:  1976-07       Impact factor: 5.226

6.  Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

7.  Antigenic specificity of neutralizing antibody to cholera toxin.

Authors:  J W Peterson; K E Hejtmancik; D E Markel; J P Craig; A Kurosky
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.

Authors:  N F Pierce; W C Cray; B K Sircar
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli.

Authors:  R B Sack; J L Froehlich
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

View more
  12 in total

1.  Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.

Authors:  F A Klipstein; R F Engert; W T Sherman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

2.  Immunological cross-reactivity of heat-labile enterotoxins produced by enterotoxigenic and enteropathogenic strains of Escherichia coli.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

3.  Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.

Authors:  P F Wright; B R Murphy; M Kervina; E M Lawrence; M A Phelan; D T Karzon
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.

Authors:  N Santiago; S Milstein; T Rivera; E Garcia; T Zaidi; H Hong; D Bucher
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

5.  Effect of antigen form on local immunoglobulin A memory response of intestinal secretions to Shigella flexneri.

Authors:  D F Keren; R A McDonald; P J Scott; A M Rosner; E Strubel
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

6.  Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

7.  Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.